Cargando…
GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects
The importance of predisposition to leukaemia in clinical practice is being increasingly recognized. This is emphasized by the establishment of a novel WHO disease category in 2016 called “myeloid neoplasms with germline predisposition”. A major syndrome within this group is GATA2 deficiency, a hete...
Autores principales: | Kotmayer, Lili, Romero‐Moya, Damia, Marin‐Bejar, Oskar, Kozyra, Emilia, Català, Albert, Bigas, Anna, Wlodarski, Marcin W., Bödör, Csaba, Giorgetti, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796058/ https://www.ncbi.nlm.nih.gov/pubmed/35753998 http://dx.doi.org/10.1111/bjh.18330 |
Ejemplares similares
-
P698: CRISPR/CAS9 GENE EDITING IN HEMATOPOIETIC STEM CELLS TO MODEL CLONAL COMPETITION IN VIVO AND IN VITRO FOR GATA2 DEFICIENCY
por: Romero-Moya, Damia, et al.
Publicado: (2023) -
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
por: Al Seraihi, Ahad F., et al.
Publicado: (2018) -
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
por: Marin-Bejar, Oskar, et al.
Publicado: (2023) -
P718: EPIGENOME PROFILING REVEALS ABERRANT DNA METHYLATION SIGNATURE IN GATA2 DEFICIENCY
por: Marin-Bejar, Oskar, et al.
Publicado: (2023) -
Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)